{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T11:37:56Z","timestamp":1780573076270,"version":"3.54.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene Reports"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.genrep.2022.101691","type":"journal-article","created":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T02:32:46Z","timestamp":1664505166000},"page":"101691","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Wharton's jelly-mesenchymal stem cells treatment for severe COVID 19 patients: 1-year follow-up"],"prefix":"10.1016","volume":"29","author":[{"given":"Mahshid","family":"Saleh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Abbas","family":"Vaezi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Ali","family":"Sohrabpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Barkhordar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Aghaghazvini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neda","family":"Alijani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javad","family":"Verdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.genrep.2022.101691_bb0005","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3109\/00365513.2014.992944","article-title":"Comparison of tumor markers and inflammatory biomarkers in chronic obstructive pulmonary disease (COPD) exacerbations","volume":"75","author":"Barouchos","year":"2015","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.genrep.2022.101691_bb0010","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1590\/1678-4685-GMB-2015-0057","article-title":"Human mesenchymal stem cells are resistant to cytotoxic and genotoxic effects of cisplatin in vitro","volume":"39","author":"Bellagamba","year":"2016","journal-title":"Genet. Mol. Biol."},{"issue":"11","key":"10.1016\/j.genrep.2022.101691_bb0015","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1634\/stemcells.2007-0197","article-title":"Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing","volume":"25","author":"Chamberlain","year":"2007","journal-title":"Stem Cells"},{"issue":"1","key":"10.1016\/j.genrep.2022.101691_bb0020","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1182\/blood-2005-07-2657","article-title":"Human mesenchymal stem cells modulate B-cell functions","volume":"107","author":"Corcione","year":"2006","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.genrep.2022.101691_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40880-015-0051-5","article-title":"Stem cell-derived exosomes: roles in stromal remodeling, tumor progression, and cancer immunotherapy","volume":"34","author":"Fatima","year":"2015","journal-title":"Chin. J. Cancer"},{"issue":"12","key":"10.1016\/j.genrep.2022.101691_bb0030","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12947","article-title":"Safety and feasibility of umbilical cord mesenchymal stem cells in patients with COVID-19 pneumonia: a pilot study","volume":"53","author":"Feng","year":"2020","journal-title":"Cell Prolif."},{"issue":"1","key":"10.1016\/j.genrep.2022.101691_bb0035","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.cgh.2013.06.021","article-title":"A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn's disease refractory to biologic therapy","volume":"12","author":"Forbes","year":"2014","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.genrep.2022.101691_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-021-02165-4","article-title":"Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series","volume":"12","author":"Hashemian","year":"2021","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"10.1016\/j.genrep.2022.101691_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1478-811X-9-12","article-title":"Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC","volume":"9","author":"Hass","year":"2011","journal-title":"Cell Commun. Signal"},{"issue":"10223","key":"10.1016\/j.genrep.2022.101691_bb0050","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"issue":"10270","key":"10.1016\/j.genrep.2022.101691_bb0055","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0140-6736(20)32656-8","article-title":"6-month consequences of COVID-19 in patients discharged from hospital: a cohort study","volume":"397","author":"Huang","year":"2021","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.genrep.2022.101691_bb0060","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.imlet.2015.05.004","article-title":"Mesenchymal stromal cells and the innate immune response","volume":"168","author":"Le Blanc","year":"2015","journal-title":"Immunol. Lett."},{"issue":"4","key":"10.1016\/j.genrep.2022.101691_bb0065","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.bbrc.2014.03.051","article-title":"Low immunogenicity of allogeneic human umbilical cord blood-derived mesenchymal stem cells in vitro and in vivo","volume":"446","author":"Lee","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.genrep.2022.101691_bb0070","doi-asserted-by":"crossref","first-page":"216","DOI":"10.14336\/AD.2020.0228","article-title":"Transplantation of ACE2-mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia","volume":"11","author":"Leng","year":"2020","journal-title":"Aging Dis."},{"issue":"4","key":"10.1016\/j.genrep.2022.101691_bb0075","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jcyt.2014.12.004","article-title":"Safety and biodistribution study of bone marrow\u2013derived mesenchymal stromal cells and mononuclear cells and the impact of the administration route in an intact porcine model","volume":"17","author":"M\u00e4kel\u00e4","year":"2015","journal-title":"Cytotherapy"},{"issue":"11","key":"10.1016\/j.genrep.2022.101691_bb0080","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1242\/jcs.02932","article-title":"Mesenchymal stem cells reside in virtually all post-natal organs and tissues","volume":"119","author":"Meirelles","year":"2006","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.genrep.2022.101691_bb0085","first-page":"E71","article-title":"Expanded umbilical cord mesenchymal stem cells (UC-MSCs) as a therapeutic strategy in managing critically ill COVID-19 patients: the case for compassionate use","volume":"23","author":"Orleans","year":"2020","journal-title":"Pain Physician"},{"issue":"1","key":"10.1016\/j.genrep.2022.101691_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-021-02483-7","article-title":"Cell therapy in patients with COVID-19 using Wharton\u2019s jelly mesenchymal stem cells: a phase 1 clinical trial","volume":"12","author":"Saleh","year":"2021","journal-title":"Stem Cell Res Ther"},{"issue":"16","key":"10.1016\/j.genrep.2022.101691_bb0095","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1001\/jama.2020.4783","article-title":"Treatment of 5 critically ill patients with COVID-19 with convalescent plasma","volume":"323","author":"Shen","year":"2020","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.genrep.2022.101691_bb0100","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1473-3099(20)30086-4","article-title":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study","volume":"20","author":"Shi","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.genrep.2022.101691_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103789","article-title":"Human mesenchymal stem cells treatment for severe COVID-19: 1-year follow-up results of a randomized, double-blind, placebo-controlled trial","volume":"75","author":"Shi","year":"2022","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.genrep.2022.101691_bb0110","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/thx.41.1.17","article-title":"Effect of cigarette smoking, pulmonary inflammation, and lung disease on concentrations of carcinoembryonic antigen in serum and secretions","volume":"41","author":"Stockley","year":"1986","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.genrep.2022.101691_bb0115","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1007\/s11684-020-0810-9","article-title":"Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19","volume":"14","author":"Tang","year":"2020","journal-title":"Front. Med."},{"issue":"7","key":"10.1016\/j.genrep.2022.101691_bb0120","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1002\/stem.1118","article-title":"Analysis of tissues following mesenchymal stromal cell therapy in humans indicates limited long-term engraftment and no ectopic tissue formation","volume":"30","author":"Von Bahr","year":"2012","journal-title":"Stem Cells"},{"issue":"12","key":"10.1016\/j.genrep.2022.101691_bb0125","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.3727\/096368911X582769c","article-title":"Allogeneic mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus: 4 years of experience","volume":"22","author":"Wang","year":"2013","journal-title":"Cell Transplant."},{"issue":"11","key":"10.1016\/j.genrep.2022.101691_bb0130","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/ni.3002","article-title":"Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications","volume":"15","author":"Wang","year":"2014","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.genrep.2022.101691_bb0135","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/jmv.25689","article-title":"Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China","volume":"92","author":"Wang","year":"2020","journal-title":"J. Med. Virol."},{"issue":"13","key":"10.1016\/j.genrep.2022.101691_bb0140","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.genrep.2022.101691_bb0145","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S2213-2600(21)00174-0","article-title":"3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study","volume":"9","author":"Wu","year":"2021","journal-title":"Lancet Respir. Med."},{"issue":"4","key":"10.1016\/j.genrep.2022.101691_bb0150","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir. Med."}],"container-title":["Gene Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452014422001996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452014422001996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:23:07Z","timestamp":1762528987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452014422001996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":30,"alternative-id":["S2452014422001996"],"URL":"https:\/\/doi.org\/10.1016\/j.genrep.2022.101691","relation":{},"ISSN":["2452-0144"],"issn-type":[{"value":"2452-0144","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Wharton's jelly-mesenchymal stem cells treatment for severe COVID 19 patients: 1-year follow-up","name":"articletitle","label":"Article Title"},{"value":"Gene Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.genrep.2022.101691","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101691"}}